Vasopressin treats the persistent feeling of coldness after brain injury.
In this pilot study, 6 patients who complained of persisting coldness after brain injury were treated with intranasal vasopressin (DDAVP) twice daily for 1 month. Response was assessed after 1 month of treatment, DDAVP was discontinued, and response was reassessed 1 month later. Five of the 6 patients had a dramatic response to DDAVP, as soon as 1 week after initiating treatment, and no longer complained of feeling cold. Response persisted even after discontinuation of treatment. Patients denied any side effects from treatment with DDAVP. The experience of persisting coldness can respond dramatically to brief treatment with intranasal DDAVP. The authors discuss possible mechanisms of action to explain this phenomenon.
Silver
J M
JM
New York University School of Medicine, New York, USA. Jonsilver@aol.com
Anderson
K
K
D000293:Adolescent; D000328:Adult; D001831:Body Temperature; D001930:Brain Injuries / Q000188:drug therapy*; D003080:Cold Temperature; D005260:Female; D006801:Humans; D008875:Middle Aged; D010865:Pilot Projects; D014667:Vasopressins / Q000627:therapeutic use*
D014667:Vasopressins